Comparison of LightCycler-based PCR, COBAS amplicor CMV monitor, and pp65 antigenemia assays for quantitative measurement of cytomegalovirus viral load in peripheral blood specimens from patients after solid organ transplantation

Journal of Clinical Microbiology

Volumn 41, Issue 7, 2003, Pages 3167-3174

  Pang, Xiaoli L ^a   Chui, Linda ^a   Fenton, Jayne ^a   LeBlanc, Barbara ^a   Preiksaitis, Jutta K ^a  

^a UNIVERSITY OF ALBERTA HOSPITAL   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; BLOOD SAMPLING; CLINICAL ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; COST EFFECTIVENESS ANALYSIS; CROSS REACTION; CYTOMEGALOVIRUS; CYTOMEGALOVIRUS INFECTION; DIAGNOSTIC ACCURACY; DIAGNOSTIC VALUE; EPSTEIN BARR VIRUS; GENE AMPLIFICATION; HERPES SIMPLEX VIRUS; HIGH RISK POPULATION; HUMAN; IMMUNOASSAY; INTERMETHOD COMPARISON; ORGAN TRANSPLANTATION; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; VARICELLA ZOSTER VIRUS; VIRUS DETECTION; VIRUS DIAGNOSIS; VIRUS LOAD;

CYTOMEGALOVIRUS; CYTOMEGALOVIRUS INFECTIONS; DNA, VIRAL; HUMANS; ORGAN TRANSPLANTATION; PHOSPHOPROTEINS; POLYMERASE CHAIN REACTION; REAGENT KITS, DIAGNOSTIC; REGRESSION ANALYSIS; SENSITIVITY AND SPECIFICITY; VIRAL LOAD; VIRAL MATRIX PROTEINS;

CUCUMBER MOSAIC VIRUS; CYTOMEGALOVIRUS; DNA VIRUSES; HUMAN HERPESVIRUS 3; HUMAN HERPESVIRUS 4; SIMPLEXVIRUS;

EID: 0038506835     PISSN: 00951137     EISSN: None     Source Type: Journal    
DOI: 10.1128/JCM.41.7.3167-3174.2003     Document Type: Article

References (35)

1. Aitken, C., W. Barrett-Muir, C. Millar, K. Templeton, J. Thomas, F. Sheridan, D. Jeffries, M. Yaqoob, and J. Breuer. 1999. Use of molecular assays in diagnosis and monitoring of cytomegalovirus disease following renal transplantation. J. Clin. Microbiol. 37:2804-2807.
2. Bai, X., G. Hosler, B. B. Rogers, D. B. Dawson, and R. H. Scheuermann. 1997. Quantitation polymerase chain reaction for human herpesvirus diagnosis and measurement of Epstein-Barr virus burden in posttransplant lymphoproliferative disorder. Clin. Chem. 43:1843-1849.
3. Boeckh, M., R. A. Bowden, J. M. Goodrich, M. Pettinger, and J. D. Meyers. 1992. Cytomegalovirus antigen detection in peripheral blood leukocytes after allogeneic marrow transplantation. Blood 80:1358-1364.
4. Boeckh, M., and G. Boivin. 1998. Quantitation of cytomegalovirus: methodologic aspects and clinical applications. Clin. Microbiol. Rev. 11:533-554.
5. Caliendo, A. M., R. Schuurman, B. Yen-Lieberman, S. A. Spector, J. Andersen, R. Manjiry, C. Crumpacker, N. S. Lurain, and A. Erice. 2001. Comparison of quantitative and qualitative PCR assays for cytomegalovirus DNA in plasma. J. Clin. Microbiol. 39:1334-1338.
6. Caliendo, A. M., K. St. George, S. Y. Kao, J. Allega, B. H. Tan, R. LaFontaine, L. Bui, and C. R. Rinaldo. 2000. Comparison of quantitative cytomegalovirus (CMV) PCR in plasma and CMV antigenemia assay: clinical utility of the prototype Amplicor CMV Monitor test in transplant recipients. J. Clin. Microbiol. 38:2122-2127.
7. Crossi, P., S. Kusne, K. St. George, M. Magnone, J. Rakela, J. Fung, and T. E. Starzl. 1996. Guidance of ganciclovir therapy with pp65 antigenemia in cytomegalovirus-free recipients of livers from seropositive donors. Transplantation 61:1659-1660.
8. Emery, V. C., C. A. Sabin, A. V. Cope, D. Gor, A. F. Hassan-Walker, and P. D. Griffiths. 2000. Application of viral-load kinetics to identify patients who develop cytomegalovirus disease after transplantation. Lancet 355:2032-2036.
9. Gerna, G., D. Zipeto, M. Parea, M. G. Revello, E. Silini, E. Percivalle, M. Zavattoni, P. Grossi, and G. Milanesi. 1991. Monitoring of human cytomegalovirus infections and ganciclovir treatment in heart transplant recipients by determination of viremia, antigenemia, and DNAemia. J. Infect. Dis. 164: 488-498.
10. Greenlee, D. J., H. Fan, K. Lawless, C. R. Harrison, and M. L. Gulley. 2002. Quantitation of CMV by real-time PCR in transfusable RBC units. Transfusion 42:403-408.
11. Guiver, M., A. J. Fox, K. Mutton, N. Mogulkoc, and J. Egan. 2001. Evaluation of CMV viral load using TaqMan CMV quantitative PCR and comparison with CMV antigenemia in heart and lung transplant recipients. Transplantation 71:1609-1615.
12. Haberland, M., U. Meyer-König, and F. T. Hufert. 1999. Variation within the glycoprotein B gene of human cytomegalovirus is due to homologous recombination. J. Gen. Virol. 80:1495-1500.
13. Humar, A., D. Kumar, G. Boivin, and A. M. Caliendo. 2002. Cytomegalovirus (CMV) virus load kinetics to predict recurrent disease in solid-organ transplant patients with CMV disease. J. Infect. Dis. 186:829-833.
14. Kearns, A. M., A. J. Turner, and R. Freeman. 2002. Rapid detection and quantification of CMV DNA in urine using LightCycler-based real-time PCR. J. Clin. Virol. 24:131-134.
15. Kizilisik, T. A., J. K. Preiksaitis, and N. M. Kneteman. 1993. Cytomegalovirus disease in liver transplant recipients: impact of acyclovir prophylaxis. Transplant Proc. 25:2282-2283.
16. Landry, M. L., D. Ferguson, S. Cohen, K. Huber, and P. Wetherill. 1995. Effect of delayed specimen processing on cytomegalovirus antigenemia test results. J. Clin. Microbiol. 33:257-259.
17. Nitsche, A., N. Steuer, C. A. Schmidt, O. Landt, and W. Siegert. 1999. Different real-time PCR formats compared for the quantitative detection of human cytomegalovirus DNA. Clin. Chem. 45:1932-1937.
18. Patel, R., T. F. Smith, M. Espy, D. Portela, R. H. Wiesner, R. A. Krom, and C. V. Paya. 1995. A prospective comparison of molecular diagnostic techniques for the early detection of cytomegalovirus in liver transplant recipients. J. Infect. Dis. 171:1010-1014.
19. Pellegrin, I., I. Garrigue, D. Ekouevi, L. Couzi, P. Merville, P. Merel, G. Chene, M. H. Schrive, P. Trimoulet, M. E. Lafon, and H. Fleury. 2000. New molecular assay to predict occurrence of cytomegalovirus disease in renal transplant recipients. Infect. Dis. 25:36-42.
20. Piiparinen, H., K. Hockerstedt, M. Lappalainen, J. Suni, and I. Lautenschlager. 2002. Monitoring of viral load by quantitative plasma PCR during active cytomegalovirus infection of individual liver transplant patients. J. Clin. Microbiol. 40:2945-2952.
21. Preiser, W., H. F. Rabenau, J. U. Vogel, V. Brixner, and H. W. Doerr. 2002. Performance characteristics of an automated PCR assay for the quantification of cytomegalovirus DNA in plasma. J. Virol. Methods 101:149-157.
22. Razonable, R. R., C. V. Paya, and T. F. Smith. 2002. Role of the laboratory in diagnosis and management of cytomegalovirus infection in hematopietic stem cell and solid-organ transplant recipients. J. Clin. Microbiol. 40:746-752.
23. Richardson, W. P., R. B. Colvin, S. H. Cheeseman, N. E. Tolkoff-Rubin, J. T. Herrin, A. B. Cosimi, A. B. Collins, M. S. Hirsch, R. T. McCluskey, P. S. Russell, and R. H. Rubin. 1981. Glomerulopathy associated with cytomegalovirus viremia in renal allografts. N. Engl. J. Med. 305:57-63.
24. Roberts, T. C., D. C. Brennan, R. S. Buller, M. Gaudreault-Keener, M. A. Schnitzler, K. E. Sternhell, K. A. Garlock, G. G. Singer, and G. A. Storch. 1998. Quantitative polymerase chain reaction to predict occurrence of symptomatic cytomegalovirus infection and assess response to ganciclovir therapy in renal transplant recipients. J. Infect. Dis. 178:626-635.
25. Rollag, H., S. Sagedal, K. I. Kristiansen, D. Kvale, E. Holter, M. Degre, and K. P. Nordal. 2002. Cytomegalovirus DNA concentration in plasma predicts development of cytomegalovirus disease in kidney transplant recipients. J. Clin. Microbiol. 8:431-434.
26. Schaade, L., P. Kockelkorn, K. Ritter, and M. Kleines. 2000. Detection of cytomegalovirus DNA in human specimens by LightCycler PCR. J. Clin. Microbiol. 38:4006-4009.
27. Schaade, L., P. Kockelkorn, K. Ritter, and M. Kleines. 2001. Detection of cytomegalovirus DNA in human specimens by LightCycler PCR: melting point analysis is mandatory to detect virus strains with point mutations in the target sequence of the hybridization probes. J. Clin. Microbiol. 39:3809.
28. Seropian, S., D. Ferguson, E. Salloum, D. Cooper, and M. L. Landry. 1998. Lack of reactivity to CMV pp65 antigenemia testing in a patient with CMV disease following allogeneic bone marrow transplant. Bone Marrow Transplant. 22:507-509.
29. Shapiro, A. M., V. G. Bain, J. K. Preiksaitis, M. M. Ma, S. Issa, and N. M. Kneteman. 2000. Ogilvie's syndrome associated with acute cytomegaloviral infection after liver transplantation. Transplant. Int. 13:41-45.
30. Sia, I. G., J. A. Wilson, M. J. Espy, C. V. Paya, and T. F. Smith. 2000. Evaluation of the COBAS Amplicor CMV Monitor test for detection of viral DNA in specimens taken from patients after liver transplantation. J. Clin. Microbiol. 38:600-606.
31. Stratta, R. J., M. S. Shaeffer, R. S. Markin, R. P. Wood, A. N. Langnas, E. C. Reed, J. P. Donovan, G. L. Woods, K. A. Bradshaw, T. J. Pillen, et al. 1992. Cytomegalovirus infection and disease after liver transplantation: an overview. Dig. Dis. Sci. 37:673-688.
32. Tanaka, N., H. Kimura, K. Iida, Y. Saito, I. Tsuge, A. Yoshimi, T. Matsuyama, and T. Morishima. 2000. Quantitative analysis of cytomegalovirus load using a real-time PCR assay. J. Med. Virol. 60:455-462.
33. Weber, B., U. Nestler, W. Ernst, H. Rabenau, J. Braner, A. Birkenbach, E. H. Scheuermann, W. Schoeppe, and H. W. Doerr. 1994. Low correlation of human cytomegalovirus DNA amplification by polymerase chain reaction with cytomegalovirus disease in organ transplant recipients. J. Med. Virol. 43:187-193.
34. Wirgart, B. Z., M. Brytting, A. Linde, B. Wahren, and L. Grillner. 1998. Sequence variation within three important cytomegalovirus gene regions in isolates from four different patient populations. J. Clin. Microbiol. 36:3662-3669.
35. Yun, Z., I. Lewensohn-Fuchs, P. Ljungman, and A. Vahlne. 2000. Real-time monitoring of cytomegalovirus infections after stem cell transplantation using the TaqMan polymerase chain reaction assays. Transplantation 69:1733-1736.